臨牀消化器内科 Vol.17 No.10(5-2)


特集名 膵・胆管合流異常 -- 最近の話題
題名 治療 (2) 胆管拡張を伴わない合流異常 a. 分流手術の是非と問題点 -- 2. 成人
発刊年月 2002年 09月
著者 松原 俊樹 藤田保健衛生大学消化器外科
著者 船曳 孝彦 藤田保健衛生大学消化器外科
著者 落合 正宏 藤田保健衛生大学消化器外科
著者 桜井 洋一 藤田保健衛生大学消化器外科
著者 長谷川 茂 藤田保健衛生大学消化器外科
著者 今津 浩喜 藤田保健衛生大学消化器外科
【 要旨 】 膵・胆管合流異常では胆道拡張を伴うものと伴わないものとがあり,臨床的に分けて考えられている.しかし合流異常の胆管形態は複雑で,かつ胆管非拡張の定義がないことから厳密に胆管拡張か非拡張かを分類しがたい症例を経験する.一般に胆管非拡張合流異常では胆管癌の発生頻度が低く,合流異常に伴う臨床症状がない症例では胆嚢摘出術のみを選択する施設もあるが,われわれはさまざまな基礎的研究より非拡張胆管も拡張胆管と同じ合流異常の病態下にあり,胆管拡張の有無にかかわらずその病態は残すべきではなく,さらに非拡張胆管も前癌病変と考え,胆道発癌の予防的意味からも胆嚢摘出術に加え可能なかぎりの肝外胆管切除を行っている.しかし厳密にいえばどこまで胆管切除を行えばよいのか,さらに術後合併症,手術侵襲など十分に検討する必要がある.今後,発癌過程の解明はもとより,統一された分類の確立とそれに基づく合理的な外科的治療が望まれる.
Theme Recent Issues of Pancreaticobiliary Maljunction
Title Validity and Controversial Issues Underlying Resection of Extrahepatic Duct for Pancreaticobiliary Maljunction without Associated Biliary Dilatation in Adults
Author Toshiki Matsubara Department of Surgery, Fujita Health University School of Medicine
Author Takahiko Funabiki Department of Surgery, Fujita Health University School of Medicine
Author Masahiro Ochiai Department of Surgery, Fujita Health University School of Medicine
Author Yoichi Sakurai Department of Surgery, Fujita Health University School of Medicine
Author Shigeru Hasegawa Department of Surgery, Fujita Health University School of Medicine
Author Hiroki Imazu Department of Surgery, Fujita Health University School of Medicine
[ Summary ] In patients with pancreaticobiliary maljunction (PBM), the association of biliary dilatation is an important diagnostic point, since its pathophysiology, clinical manifestations and treatment have been believed to be distinct, depending on whether or not the cases are associated with biliary dilatation. However, because the biliary tree of patients with PBM includes a wide variety of configurations and because of the absence of a generally accepted definition of biliary dilatation, there are some cases in which we have difficulty in determining associations with biliary dilatation. It has generally been believed that, in contrast to PBM cases with biliary dilatation, the incidence of bile duct carcinoma is relatively low in patients with PBM without biliary dilatation. Therefore, simple cholecystectomy for patients with PBM without obvious clinical symptoms is, selected as the operation of choice in some institutions. However, our recent studies demonstrated that alterations in somegenes, related to the carcinogenesis of biliary epithelium in patients with PBM, occur regardless of biliary dilatation, suggesting that resection of the bile duct is necessary to eradicate the biliary epithelium, which has a high carcinogenic potential. These data clearly indicated that resection of the extrahepatic biliary duct associated with cholecystectomy for patients with PBM without the association of biliary dilatation prevents biliary carcinoma that could potentially occur in the future. Despite this evidence, the extent of resection of the biliary duct for complete prevention of biliary carcinogenesis still remains controversial. Furthermore, since the benefits of resection of the extrahepatic bile duct in preventing biliary carcinogenesis should be balanced against the operative risks for these patients, postoperative complicationsand surgical invasiveness of the operation should carefully be evaluated. Preparation of generally accepted criteria or classification of PBM, as well as further basic research regarding the mechanism of biliary carcinogenesis, is required to determine optimal surgical approachs for patients with PBM.
戻る